Associate Software Engineer at Moderna

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

2+ years of experience in modern full-stack web application development
Proficiency in JavaScript/TypeScript, HTML, CSS, and modern frameworks (preferably Angular and Node.js)
Experience with AWS or another cloud provider for deploying and managing applications

Responsibilities

Design, develop, and deploy full-stack TypeScript web applications using modern frameworks and cloud-native infrastructure
Collaborate with application developers to identify pain points and create reusable solutions that scale across teams
Ensure modularity and maintainability of code, emphasizing clarity and long-term usability
Drive new features from concept to deployment, ensuring seamless integration with existing tools and systems
Deliver and maintain robust test frameworks to support development agility and quality
Optimize developer experience through enhanced tooling and frameworks that accelerate application delivery
Write clear and concise documentation to empower internal teams using platform tools
Leverage AWS to deliver scalable and secure software systems in a fast-moving environment
Support continuous improvement efforts, including CI/CD pipelines and cloud infrastructure evolution
Stay current with advancements in software engineering and contribute learnings back to the team and broader community
Participate in multiple concurrent projects in an agile, collaborative, and fast-paced setting

Skills

CI/CD

Cloud Infrastructure

Web Development

Software Frameworks

Application Design

Full-Stack Development

Moderna

Develops mRNA-based medicines for health

About Moderna

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.

Cambridge, MassachusettsHeadquarters

2010Year Founded

$5,925.5MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees